BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 15106227)

  • 1. Valproic acid for agitation in dementia.
    Lonergan ET; Cameron M; Luxenberg J
    Cochrane Database Syst Rev; 2004; (2):CD003945. PubMed ID: 15106227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproate preparations for agitation in dementia.
    Lonergan E; Luxenberg J
    Cochrane Database Syst Rev; 2009 Jul; (3):CD003945. PubMed ID: 19588348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproate preparations for agitation in dementia.
    Baillon SF; Narayana U; Luxenberg JS; Clifton AV
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD003945. PubMed ID: 30293233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haloperidol for agitation in dementia.
    Lonergan E; Luxenberg J; Colford J
    Cochrane Database Syst Rev; 2001; (4):CD002852. PubMed ID: 11687166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
    Macritchie KA; Geddes JR; Scott J; Haslam DR; Goodwin GM
    Cochrane Database Syst Rev; 2001; (3):CD003196. PubMed ID: 11687047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
    Cipriani A; Reid K; Young AH; Macritchie K; Geddes J
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD003196. PubMed ID: 24132760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haloperidol for agitation in dementia.
    Lonergan E; Luxenberg J; Colford J
    Cochrane Database Syst Rev; 2002; (2):CD002852. PubMed ID: 12076456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.
    Forester B; Vanelli M; Hyde J; Perez R; Ahokpossi C; Sribney W; Adkison L
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placebo-controlled study of divalproex sodium for agitation in dementia.
    Porsteinsson AP; Tariot PN; Erb R; Cox C; Smith E; Jakimovich L; Noviasky J; Kowalski N; Holt CJ; Irvine C
    Am J Geriatr Psychiatry; 2001; 9(1):58-66. PubMed ID: 11156753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.
    Ballard C; Waite J
    Cochrane Database Syst Rev; 2006 Jan; (1):CD003476. PubMed ID: 16437455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults.
    Linde M; Mulleners WM; Chronicle EP; McCrory DC
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD010611. PubMed ID: 23797677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divalproex sodium therapy in elderly with dementia-related agitation.
    Pratt CE; Davis SM
    Ann Pharmacother; 2002 Oct; 36(10):1625-8. PubMed ID: 12243614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproate therapy for agitation in dementia: open-label extension of a double-blind trial.
    Porsteinsson AP; Tariot PN; Jakimovich LJ; Kowalski N; Holt C; Erb R; Cox C
    Am J Geriatr Psychiatry; 2003; 11(4):434-40. PubMed ID: 12837672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divalproex sodium in nursing home residents with possible or probable Alzheimer Disease complicated by agitation: a randomized, controlled trial.
    Tariot PN; Raman R; Jakimovich L; Schneider L; Porsteinsson A; Thomas R; Mintzer J; Brenner R; Schafer K; Thal L; ;
    Am J Geriatr Psychiatry; 2005 Nov; 13(11):942-9. PubMed ID: 16286437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults.
    Gill D; Derry S; Wiffen PJ; Moore RA
    Cochrane Database Syst Rev; 2011 Oct; 2011(10):CD009183. PubMed ID: 21975791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of valproic acid versus haloperidol in patients with acute agitation: results of a randomized, double-blind, parallel-group trial.
    Asadollahi S; Heidari K; Hatamabadi H; Vafaee R; Yunesian S; Azadbakht A; Mirmohseni L
    Int Clin Psychopharmacol; 2015 May; 30(3):142-50. PubMed ID: 25500684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproic acid treatment of agitation in dementia.
    Herrmann N
    Can J Psychiatry; 1998 Feb; 43(1):69-72. PubMed ID: 9494750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of divalproex sodium in the treatment of agitation associated with major depression.
    Debattista C; Solomon A; Arnow B; Kendrick E; Tilston J; Schatzberg AF
    J Clin Psychopharmacol; 2005 Oct; 25(5):476-9. PubMed ID: 16160625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trazodone for agitation in dementia.
    Martinon-Torres G; Fioravanti M; Grimley EJ
    Cochrane Database Syst Rev; 2004 Oct; (4):CD004990. PubMed ID: 15495135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anticonvulsant mood stabilizers in the treatment of behavioral and psychological symptoms of dementia (BPSD)].
    Pinheiro D
    Encephale; 2008 Sep; 34(4):409-15. PubMed ID: 18922244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.